Search Results - "Glover, Sarah"

Refine Results
  1. 1

    Getting by With Less: How to do More With Less Staff After COVID-19? by Reeves, Vonda, Schaefer, David, Glover, Sarah C.

    Published in The American journal of gastroenterology (01-10-2022)
    “…[...]it will be imperative that institutions address parity for nurses and technicians so that their compensation is akin to operating room personnel (Table…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Immune marker reductions in black and white Americans following sleeve gastrectomy in the short-term phase of surgical weight loss by Phillips, Charles L, Le, Tran T, Lirette, Seth T, Welch, Bradley A, Glover, Sarah C, Dungey, Adam, Vick, Kenneth D, Grayson, Bernadette E

    Published in PloS one (25-07-2023)
    “…Surgical weight loss procedures like vertical sleeve gastrectomy (SG) are sufficient in resolving obesity comorbidities and are touted to reduce the burden of…”
    Get full text
    Journal Article
  4. 4

    Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease by Stewart, Daniel C, Berrie, Dalton, Li, Jian, Liu, Xinyue, Rickerson, Cooper, Mkoji, David, Iqbal, Atif, Tan, Sanda, Doty, Andria L, Glover, Sarah C, Simmons, Chelsey S

    Published in PloS one (11-07-2018)
    “…Inflammatory bowel disease (IBD) continues to increase in prevalence in industrialized countries. Major complications of IBD include formation of fibrotic…”
    Get full text
    Journal Article
  5. 5

    Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease by Danese, Silvio, Sandborn, William J., Colombel, Jean-Frédéric, Vermeire, Séverine, Glover, Sarah C., Rimola, Jordi, Siegelman, Jenifer, Jones, Stephen, Bornstein, Jeffrey D., Feagan, Brian G.

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-2019)
    “…Vedolizumab is a gut-selective monoclonal antibody for the treatment of moderately to severely active Crohn’s disease (CD). We performed a prospective study of…”
    Get full text
    Journal Article
  6. 6

    Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy by Chen, Chao, Hartzema, Abraham G, Xiao, Hong, Wei, Yu-Jung, Chaudhry, Naueen, Ewelukwa, Ofor, Glover, Sarah C, Zimmermann, Ellen M

    Published in Inflammatory bowel diseases (17-07-2019)
    “…Medication persistence, defined as the time from drug initiation to discontinuation of therapy, has been suggested as a proxy for real-world therapeutic…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis by Mateja, Allyson, Wang, Qinlu, Chovanec, Jack, Kim, Jiwon, Wilson, Kenneth J., Schwartz, Lawrence B., Glover, Sarah C., Carter, Melody C., Metcalfe, Dean D., Brittain, Erica, Lyons, Jonathan J.

    Published in Journal of allergy and clinical immunology (01-03-2022)
    “…Acute increases of ≥20% + 2 ng/mL (20 + 2 rule) over basal serum tryptase (BST) is the recommended threshold supporting a clinical diagnosis of anaphylaxis…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Innate Lymphoid Cells in Inflammatory Bowel Disease by Li, Jian, Glover, Sarah C.

    “…Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a complex chronic inflammatory condition of the human gut of unknown…”
    Get full text
    Journal Article
  12. 12

    Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates by Falcon, Benjamin, Cavallini, Annalisa, Angers, Rachel, Glover, Sarah, Murray, Tracey K., Barnham, Luanda, Jackson, Samuel, O'Neill, Michael J., Isaacs, Adrian M., Hutton, Michael L., Szekeres, Philip G., Goedert, Michel, Bose, Suchira

    Published in The Journal of biological chemistry (09-01-2015)
    “…Intracellular Tau inclusions are a pathological hallmark of several neurodegenerative diseases, collectively known as the tauopathies. They include Alzheimer…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond by Glover, Sarah C, Carter, Melody C, Korošec, Peter, Bonadonna, Patrizia, Schwartz, Lawrence B, Milner, Joshua D, Caughey, George H, Metcalfe, Dean D, Lyons, Jonathan J

    Published in Annals of allergy, asthma, & immunology (01-12-2021)
    “…To describe our current understanding of hereditary α-tryptasemia (HαT), how HαT fits into the evolutionary context of tryptases and contemporary framework of…”
    Get full text
    Journal Article
  16. 16

    Parent-carer experiences using a peer support network: a qualitative study by Gudka, Rebecca, Kelman, Charlotte, Bryant, Eleanor, Farooq, Bushra, Berry, Vashti, Bjornstad, Gretchen, Martin, Faith, Glover, Sarah-Lou, Russell, Abigail

    Published in BMC public health (16-10-2023)
    “…Abstract Introduction Parent-carers of children and young people (CYP) with mental health problems are at greater risk of poor outcomes, such as poor physical…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Response to Cheng et al by Liu, Julia J., Owings, Anna H., Claggett, Brian, Robinson, Tanya, Glover, Sarah C.

    Published in The American journal of gastroenterology (01-12-2021)
    “…Regarding the exact period of proton pump inhibitor (PPI) use, we agree that it would be helpful to know the exact length of time that individuals have been on…”
    Get full text
    Journal Article
  19. 19

    COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells by Darwish, Sara, Liu, Lauren P, Robinson, Tanya O, Tarugu, Spurthi, Owings, Anna H, Glover, Sarah C, Alli, Abdel A

    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is the causative agent of the COVID-19 disease. COVID-19 viral infection can affect many…”
    Get full text
    Journal Article
  20. 20